FDA NDC Directory · JSON-LD · Markdown

Repaglinide

NDC 62135-948 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerChartwell RX, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA078555
Dosage form / routeTABLET · ORAL
Active ingredientsREPAGLINIDE (2 mg/1)
Marketing started20140122
Package count1

External sources

Source: openFDA. Public-domain (CC0).